An Indian real-world experience of intravenous fosnetupitant-palonosetron (IV NEPA) in preventing delayed and extended delayed CINV.

Authors

null

Hanmant V. Barkate

Glenmark Pharmaceuticals Ltd, Mumbai, India

Hanmant V. Barkate , Dr. Amullya Pednekar , Pragya Shukla , Shaunak Valame , Siddhartha Nanda , Abhinandan Hanji , Naval Kishore Shakya , Arun Kumar Verma , Sagar B Bhagat , Saiprasad Patil , Sumit Bhushan

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Symptom Science and Palliative Care

Track

Symptom Science and Palliative Care

Sub Track

Palliative Care and Symptom Management

Clinical Trial Registration Number

CTRI/2023/04/051951

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr 12070)

DOI

10.1200/JCO.2024.42.16_suppl.12070

Abstract #

12070

Poster Bd #

199

Abstract Disclosures

Similar Posters

Poster

2016 Palliative and Supportive Care in Oncology Symposium

Efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with gastrointestinal and colorectal cancers.

Efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with gastrointestinal and colorectal cancers.

First Author: Rudolph M. Navari

Poster

2020 ASCO Virtual Scientific Program

Antiemetic prophylaxis with NEPA: Final results of the German AKYPRO study.

Antiemetic prophylaxis with NEPA: Final results of the German AKYPRO study.

First Author: Joerg Peter Schilling